87 related articles for article (PubMed ID: 1776843)
1. Cytotoxic effects of a new antitumor antibiotic, FK973, in malignant glioma.
Moriuchi S; Shimizu K; Yamada M; Mabuchi E; Tamura K; Park KC; Hayakawa T
Anticancer Res; 1991; 11(6):2079-84. PubMed ID: 1776843
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor efficacy of FK 973 on malignant glioma cells].
Shimizu K; Yamada M; Mabuchi E; Matsui Y; Tamura K; Moriuchi S; Park K; Mogami H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2367-72. PubMed ID: 2751317
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor activity of FK973 for malignant gliomas and its assessment for normal brain cells].
Moriuchi S; Shimizu K; Yamada M; Mabuchi E; Tamura K; Park K; Hayakawa T; Mogami H
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2774-80. PubMed ID: 2074387
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of FK973 against human oral and breast cancer cells.
Wu JZ; Adachi I; Watanabe T
Chin Med J (Engl); 1991 Oct; 104(10):834-7. PubMed ID: 1661225
[TBL] [Abstract][Full Text] [Related]
6. Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.
Nakamura T; Masuda K; Matsumoto S; Oku T; Manda T; Mori J; Shimomura K
Jpn J Pharmacol; 1989 Mar; 49(3):317-24. PubMed ID: 2501546
[TBL] [Abstract][Full Text] [Related]
7. Interstrand DNA-DNA and DNA-protein cross-links by a new antitumor antibiotic, FK973, in L1210 cells.
Masuda K; Nakamura T; Mizota T; Mori J; Shimomura K
Cancer Res; 1988 Sep; 48(18):5172-7. PubMed ID: 3409243
[TBL] [Abstract][Full Text] [Related]
8. A new antitumor antibiotic, FK973: its metabolism in the blood and the antitumor effects of its metabolites on experimental models.
Masuda K; Suzuki A; Nakamura T; Takagaki S; Noda K; Shimomura K; Noguchi H; Shibayama F
Jpn J Pharmacol; 1989 Oct; 51(2):219-26. PubMed ID: 2593379
[TBL] [Abstract][Full Text] [Related]
9. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; VĂ©nuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
10. Specific metabolic activation of FK973, a new antitumor antibiotic, in L1210 leukemia cells.
Masuda K; Nakamura T; Shimomura K
Jpn J Pharmacol; 1990 Aug; 53(4):463-72. PubMed ID: 2214370
[TBL] [Abstract][Full Text] [Related]
11. FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
Naoe Y; Inami M; Matsumoto S; Nishigaki F; Tsujimoto S; Kawamura I; Miyayasu K; Manda T; Shimomura K
Cancer Chemother Pharmacol; 1998; 42(1):31-6. PubMed ID: 9619755
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973).
Ho DH; Pazdur R; Brown NS; Covington WP; Raber MN; Krakoff IH
Anticancer Res; 1993; 13(2):343-6. PubMed ID: 8517646
[TBL] [Abstract][Full Text] [Related]
14. [Drug sensitivity test against malignant gliomas].
Nakamura O; Matsutani M; Nomura K; Takakura K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1151-6. PubMed ID: 1693488
[TBL] [Abstract][Full Text] [Related]
15. Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
Leggas M; Stewart CF; Woo MH; Fouladi M; Cheshire PJ; Peterson JK; Friedman HS; Billups C; Houghton PJ
Clin Cancer Res; 2002 Sep; 8(9):3000-7. PubMed ID: 12231547
[TBL] [Abstract][Full Text] [Related]
16. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay.
Horiuchi N; Nakagawa K; Sasaki Y; Minato K; Fujiwara Y; Nezu K; Ohe Y; Saijo N
Cancer Chemother Pharmacol; 1988; 22(3):246-50. PubMed ID: 2842080
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
Geoerger B; Kerr K; Tang CB; Fung KM; Powell B; Sutton LN; Phillips PC; Janss AJ
Cancer Res; 2001 Feb; 61(4):1527-32. PubMed ID: 11245461
[TBL] [Abstract][Full Text] [Related]
18. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
Takahashi H; Adachi K; Yamaguchi F; Teramoto A
Anticancer Res; 1999; 19(5B):4151-5. PubMed ID: 10628367
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites].
Kubo O; Himuro H; Inoue N; Tajika Y; Tajika T; Tohyama T; Sakairi M; Yoshida M; Kaetsu I; Kitamura K
No Shinkei Geka; 1986 Sep; 14(10):1189-95. PubMed ID: 3024049
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]